Richard Piekarz

13PUBLICATIONS
134CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursMolecular medicineApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 29, 2025
Cutaneous T-Cell Lymphoma: Yin-Yang Effects of Transcription Factors HLF and NFIL3 in Regulation of Malignant T-Cell Markers in the Context of HDAC Inhibitor Romidepsin Treatment.

Andrew V Kossenkov, Noor Dawany, Sonali Majumdar

|Mar 19, 2025
A Phase I Study of Nilotinib in Combination with Paclitaxel in Patients with Advanced Solid Tumors.

Sarah J Shin, Geraldine O'Sullivan Coyne, Shivaani Kummar

|Oct 22, 2024
Phase II Study of Palbociclib in Patients with Tumors with CDK4 or CDK6 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1C.

Mark H O'Hara, Opeyemi Jegede, Mark A Dickson

|Aug 09, 2023
Phase I Study of Entinostat, Atezolizumab, Carboplatin, and Etoposide in Previously Untreated Extensive-Stage Small Cell Lung Cancer, ETCTN 10399.

Ryan D Gentzler, Liza C Villaruz, John C Rhee

|Oct 27, 2022
A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma.

John A Ligon, R Taylor Sundby, Mary F Wedekind

|Jul 27, 2022
Quantitation of navtemadlin in human plasma and brain tissue by liquid chromatography-tandem mass spectrometry.

Amanda B Kagan, Nicole M Anders, Avelina Hemingway

Pageof 3

Frequent Collaborators

4 joint publications

Lawrence V Rubinstein

4 joint publications

Alice P Chen

3 joint publications

Geraldine O'Sullivan Coyne

3 joint publications

Michelle A Rudek